# [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer

> **NCT04972682** · NA · COMPLETED · sponsor: **Moscow City Oncology Hospital No. 62** · enrollment: 102 (actual)

## Conditions studied

- Endometrial Cancer
- Endometrial Neoplasms
- Endometrial Adenocarcinoma
- Endometrial Cancer Stage I
- Endometrial Cancer Stage II
- Endometrial Endometrioid Adenocarcinoma
- Sentinel Lymph Node
- Hysterectomy
- Laparoscopic Hysterectomy

## Interventions

- **PROCEDURE:** Laparoscopic total hysterectomy with bilateral salpingo-oophorectomy and sentinel lymph node biopsy

## Key facts

- **NCT ID:** NCT04972682
- **Lead sponsor:** Moscow City Oncology Hospital No. 62
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2023-08-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972682, "[SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk Endometrial Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04972682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*